Paclitaxel-Based Chemotherapy for Advanced Pancreatic Cancer after Gemcitabine-Based Therapy Failure: A Case Series of 5 Patients

BACKGROUND/OBJECTIVES: Gemcitabine (GEM) is a gold-standard chemotherapy agent for advanced pancreatic cancer. Because of the malignant character of the disease, nearly all patients show disease progression despite treatment with GEM-based chemotherapy; therefore, second-line chemotherapy may be ben...

Descripción completa

Detalles Bibliográficos
Autores principales: Igarashi, Hisato, Ito, Tetsuhide, Hisano, Terumasa, Fujimori, Nao, Niina, Yusuke, Yasuda, Mikihiko, Kaku, Toyoma, Matsuo, Susumu, Oono, Takamasa, Yoshinaga, Masahiro, Sakai, Hiroyuki, Takayanagi, Ryoichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2011
Materias:
Published: November, 2011
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242710/
https://www.ncbi.nlm.nih.gov/pubmed/22187539
http://dx.doi.org/10.1159/000334704

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242710/
https://www.ncbi.nlm.nih.gov/pubmed/22187539
http://dx.doi.org/10.1159/000334704

Ejemplares similares